Product Code: A01318
The increase in incidence of gynecological disorders is a pivotal driver contributing to the growth of the gynecological devices market. As the prevalence of conditions such as cervical cancer, endometriosis, and uterine fibroids rises, there is a heightened demand for advanced diagnostic and therapeutic solutions. For instance, according to the World Cancer Research Fund International report, 2020, endometrial cancer was the sixth most commonly occurring cancer in women and the 15th most common cancer overall. There were more than 417,000 new cases of endometrial cancer in 2020. Thus, the rise in gynecological disease incidences drives the demand for gynecological devices, thereby fostering market growth.
Furthermore, the growing focus on technological advancements plays a crucial role in shaping the market landscape. Ongoing innovations in medical technology, including minimally invasive surgical techniques, robotic-assisted surgeries, and advanced imaging systems, enhance the precision and efficacy of gynecological procedures. These technological advancements not only improve patient outcomes but also contribute to reduced recovery times and enhanced overall healthcare experiences. In addition, innovative devices that result from technological progress often provide healthcare professionals with better diagnostic capabilities, enabling early detection and intervention. The synergistic impact of increased disease incidence and the integration of cutting-edge technologies positions the gynecological devices market for continued expansion as healthcare systems strive to meet the evolving demands of women's health.
The gynecological devices market is segmented on the basis of product type, end user, and region. On the basis of product type, the market is segmented into gynecological endoscopy devices, endometrial ablation devices, fluid management systems, female sterilization and contraceptive devices, and diagnostic imaging systems. The gynecological endoscopy devices segment is further segmented into laparoscopes, and others. The endometrial ablation devices segment is further segmented into Hydrothermal endometrial ablation devices radiofrequency endometrial ablation devices, balloon endometrial ablation devices, and others. The female sterilization and contraceptive devices segment is further segmented into permanent birth control devices, and temporary birth control devices. The diagnostic imaging systems is further segmented into Ultrasound and Mammography. On the basis of end user, the market is segmented into hospitals, diagnostic centers, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).
The major key players that operate in the global gynecological devices market are Stryker Corporation, Richard Wolf GmbH, MedGyn Product Inc., Medtronic Plc, Boston Scientific Corporation, Karl Storz GmbH and Co. KG, Cooper Surgical, Inc., Olympus Corporation, Hologic, Inc., and Ethicon, Inc. The key players have adopted product launch and product approval as the key strategy to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the gynecological devices market analysis from 2022 to 2032 to identify the prevailing gynecological devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the gynecological devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global gynecological devices market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- Market share analysis of players at global/region/country level
Key Market Segments
By Product Type
- Diagnostic Imaging Systems
- Type
- Ultrasound
- Mammography
- Gynecological Endoscopy Devices
- Endometrial Ablation Devices
- Type
- Hydrothermal endometrial ablation devices
- Radiofrequency endometrial ablation devices
- Balloon endometrial ablation devices
- Others
- Fluid Management Systems
- Female Sterilization and Contraceptive Devices
- Type
- Permanent birth control devices
- Temporary birth control devices
By End Users
- Hospitals
- Diagnostic Centers
- Others
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Colombia
- Argentina
- Rest Of La
- Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea
Key Market Players:
- Boston Scientific Corporation
- CONMED Corporation.
- Medtronic plc
- Olympus Corporation
- Smith and Nephew plc.
- Stryker Corporation
- FUJIFILM Holdings Corporation
- HOYA Corporation
- Johnson and Johnson
- Karl Storz GmbH & Co. KG
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: GYNECOLOGICAL DEVICES MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Gynecological Endoscopy Devices
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Gynecological Endoscopy Devices Gynecological Devices Market by Type
- 4.3. Endometrial Ablation Devices
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Endometrial Ablation Devices Gynecological Devices Market by Type
- 4.4. Fluid Management Systems
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.5. Female Sterilization and Contraceptive Devices
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
- 4.5.4. Female Sterilization and Contraceptive Devices Gynecological Devices Market by Type
- 4.6. Diagnostic Imaging Systems
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country
- 4.6.4. Diagnostic Imaging Systems Gynecological Devices Market by Type
CHAPTER 5: GYNECOLOGICAL DEVICES MARKET, BY END USERS
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Hospitals
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Diagnostic Centers
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
CHAPTER 6: GYNECOLOGICAL DEVICES MARKET, BY REGION
- 6.1. Overview
- 6.1.1. Market size and forecast By Region
- 6.2. North America
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by Product Type
- 6.2.3. Market size and forecast, by End Users
- 6.2.4. Market size and forecast, by country
- 6.2.4.1. U.S.
- 6.2.4.1.1. Market size and forecast, by Product Type
- 6.2.4.1.2. Market size and forecast, by End Users
- 6.2.4.2. Canada
- 6.2.4.2.1. Market size and forecast, by Product Type
- 6.2.4.2.2. Market size and forecast, by End Users
- 6.2.4.3. Mexico
- 6.2.4.3.1. Market size and forecast, by Product Type
- 6.2.4.3.2. Market size and forecast, by End Users
- 6.3. Europe
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by Product Type
- 6.3.3. Market size and forecast, by End Users
- 6.3.4. Market size and forecast, by country
- 6.3.4.1. Germany
- 6.3.4.1.1. Market size and forecast, by Product Type
- 6.3.4.1.2. Market size and forecast, by End Users
- 6.3.4.2. France
- 6.3.4.2.1. Market size and forecast, by Product Type
- 6.3.4.2.2. Market size and forecast, by End Users
- 6.3.4.3. UK
- 6.3.4.3.1. Market size and forecast, by Product Type
- 6.3.4.3.2. Market size and forecast, by End Users
- 6.3.4.4. Italy
- 6.3.4.4.1. Market size and forecast, by Product Type
- 6.3.4.4.2. Market size and forecast, by End Users
- 6.3.4.5. Spain
- 6.3.4.5.1. Market size and forecast, by Product Type
- 6.3.4.5.2. Market size and forecast, by End Users
- 6.3.4.6. Rest of Europe
- 6.3.4.6.1. Market size and forecast, by Product Type
- 6.3.4.6.2. Market size and forecast, by End Users
- 6.4. Asia-Pacific
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by Product Type
- 6.4.3. Market size and forecast, by End Users
- 6.4.4. Market size and forecast, by country
- 6.4.4.1. Japan
- 6.4.4.1.1. Market size and forecast, by Product Type
- 6.4.4.1.2. Market size and forecast, by End Users
- 6.4.4.2. China
- 6.4.4.2.1. Market size and forecast, by Product Type
- 6.4.4.2.2. Market size and forecast, by End Users
- 6.4.4.3. India
- 6.4.4.3.1. Market size and forecast, by Product Type
- 6.4.4.3.2. Market size and forecast, by End Users
- 6.4.4.4. Australia
- 6.4.4.4.1. Market size and forecast, by Product Type
- 6.4.4.4.2. Market size and forecast, by End Users
- 6.4.4.5. South Korea
- 6.4.4.5.1. Market size and forecast, by Product Type
- 6.4.4.5.2. Market size and forecast, by End Users
- 6.4.4.6. Rest of Asia-Pacific
- 6.4.4.6.1. Market size and forecast, by Product Type
- 6.4.4.6.2. Market size and forecast, by End Users
- 6.5. Latin America
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by Product Type
- 6.5.3. Market size and forecast, by End Users
- 6.5.4. Market size and forecast, by country
- 6.5.4.1. Brazil
- 6.5.4.1.1. Market size and forecast, by Product Type
- 6.5.4.1.2. Market size and forecast, by End Users
- 6.5.4.2. Colombia
- 6.5.4.2.1. Market size and forecast, by Product Type
- 6.5.4.2.2. Market size and forecast, by End Users
- 6.5.4.3. Argentina
- 6.5.4.3.1. Market size and forecast, by Product Type
- 6.5.4.3.2. Market size and forecast, by End Users
- 6.5.4.4. Rest Of La
- 6.5.4.4.1. Market size and forecast, by Product Type
- 6.5.4.4.2. Market size and forecast, by End Users
- 6.6. Middle East and Africa
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by Product Type
- 6.6.3. Market size and forecast, by End Users
- 6.6.4. Market size and forecast, by country
- 6.6.4.1. Gcc
- 6.6.4.1.1. Market size and forecast, by Product Type
- 6.6.4.1.2. Market size and forecast, by End Users
- 6.6.4.2. South Africa
- 6.6.4.2.1. Market size and forecast, by Product Type
- 6.6.4.2.2. Market size and forecast, by End Users
- 6.6.4.3. North Africa
- 6.6.4.3.1. Market size and forecast, by Product Type
- 6.6.4.3.2. Market size and forecast, by End Users
- 6.6.4.4. Rest Of Mea
- 6.6.4.4.1. Market size and forecast, by Product Type
- 6.6.4.4.2. Market size and forecast, by End Users
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product mapping of top 10 player
- 7.4. Competitive dashboard
- 7.5. Competitive heatmap
- 7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
- 8.1. Boston Scientific Corporation
- 8.1.1. Company overview
- 8.1.2. Key executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
- 8.2. CONMED Corporation.
- 8.2.1. Company overview
- 8.2.2. Key executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
- 8.3. Medtronic plc
- 8.3.1. Company overview
- 8.3.2. Key executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
- 8.4. Olympus Corporation
- 8.4.1. Company overview
- 8.4.2. Key executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
- 8.5. Smith and Nephew plc.
- 8.5.1. Company overview
- 8.5.2. Key executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
- 8.6. Stryker Corporation
- 8.6.1. Company overview
- 8.6.2. Key executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
- 8.7. FUJIFILM Holdings Corporation
- 8.7.1. Company overview
- 8.7.2. Key executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
- 8.8. HOYA Corporation
- 8.8.1. Company overview
- 8.8.2. Key executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
- 8.9. Johnson and Johnson
- 8.9.1. Company overview
- 8.9.2. Key executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
- 8.10. Karl Storz GmbH & Co. KG
- 8.10.1. Company overview
- 8.10.2. Key executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments